ADC Therapeutics SA Price to Book Ratio 2019-2023 | ADCT
Historical price to book ratio values for ADC Therapeutics SA (ADCT) over the last 10 years. The current price to book ratio for ADC Therapeutics SA as of May 31, 2023 is 4.79.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ADC Therapeutics SA Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-06-01 |
2.38 |
|
inf |
| 2023-03-31 |
1.95 |
|
0.00 |
| 2022-12-31 |
3.84 |
|
0.00 |
| 2022-09-30 |
4.82 |
|
0.00 |
| 2022-06-30 |
7.95 |
|
0.00 |
| 2022-03-31 |
14.69 |
|
0.00 |
| 2021-12-31 |
20.20 |
$2.16 |
9.34 |
| 2021-09-30 |
27.16 |
|
0.00 |
| 2021-06-30 |
24.35 |
|
0.00 |
| 2021-03-31 |
24.41 |
|
0.00 |
| 2020-12-31 |
32.01 |
$4.37 |
7.32 |
| 2020-09-30 |
32.99 |
$4.90 |
6.73 |
| 2020-06-30 |
46.81 |
$2.78 |
16.86 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.181B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
